Release Date: Aug 2018
CC: PC, MK, PBL, SBP
Carol A. Rauch, MD, PhD
Medical Director of Virology and Rapid Response Laboratory, Vanderbilt University Medical Center, Nashville, TN; Associate Professor of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN
According to the Centers for Disease Control and Prevention, among the concerns posed by antimicrobial resistance, C. difficile is considered to represent an urgent threat in the United States. As such, this pathogen requires active monitoring and prevention in order to mitigate the risk of the life-threatening diarrhea it can cause. To meet this challenge, a multitude of laboratory testing approaches has been used, each associated with features related to performance and significance. There has been an explosion of literature in this field, and testing recommendations continue to evolve. At the same time, specimen and other practical laboratory issues continue to require education, communication, and active management. This session will review current thinking in this dynamic arena that is so critical to patient care in today’s healthcare environment.
After attending this session, participants will be able to:
- Discuss strengths and limitations of C. difficile testing methods and algorithms.
- Determine a C. difficile testing strategy appropriate for your laboratory.
- Devise a plan for specimen management relevant to C. difficile testing.
Who should attend? Practicing Pathologists, Residents, Doctoral Scientists, Laboratory Managers, Bench Supervisors, Bench Technologists and Technicians, Students